AWM
CLPT icon

Avior Wealth Management’s ClearPoint Neuro CLPT Stock Holding History

Avior Wealth Management’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4
Closed -$27 – 2544
2024
Q1 		$27 Buy
+4
New +$28 ﹤0.01% 3632

Other funds holding CLPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWM
Cahill Wealth Management Portage, Michigan $196M AUM 8.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Avior Wealth Management's CLPT Position: Q2 2024 in Review

Avior Wealth Management sold out of ClearPoint Neuro (CLPT) in Q2 2024, closing a stake of 4 shares — an estimated $27 sold.

Avior Wealth Management first reported a position in CLPT in Q1 2024 and held it in 1 quarter. The position peaked at $27 in Q1 2024. 86 funds tracked by Wall St. Rank hold CLPT as of Q2 2024.

  • Avior Wealth Management reported no remaining ClearPoint Neuro position as of Q2 2024 after selling out during the quarter.
  • Avior Wealth Management sold 4 ClearPoint Neuro shares in Q2 2024, an estimated $27.
  • Avior Wealth Management first reported a position in ClearPoint Neuro in Q1 2024 and held it in 1 quarter.
  • Avior Wealth Management's ClearPoint Neuro position peaked at $27 in Q1 2024.
  • 86 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2024.

Based on Avior Wealth Management's 13F filing for Q2 2024, filed 13 Aug 2024.